1. Hung-Lin Chen, Li-Jiuan Shen, Ping-Ning Hsu, Chieh-Yu Shen, Susan A. Hall, Fei-Yuan Hsiao. Cumulative burden of glucocorticoid-related adverse events in patients with systemic lupus erythematosus: Findings from a 12-year longitudinal study. The Journal of Rheumatology. 2018; 45(1): 83-89. doi: 10.3899/jrheum.160214. Epub 2017 Nov 15.

2. Wang CY, Fu SH, Yang RS, Shen LJ, Wu FL, Hsiao FY. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013. Archives of Osteoporosis. 2017; 12(1):92. doi: 10.1007/s11657-017-0385-5. (SCI)

3. Chang JY, Wang CC, Kang HC, Shen LJ, Huang CF. Cost-Effectiveness of the Pharmacist-assisted Warfarin Monitoring Program at a Medical Center in Taiwan. International Journal for Quality in Health Care 2017; 29(6):817-825. doi: 10.1093/intqhc/mzx109. (SCI, SSCI)

4. 蘇靖晏, 沈麗娟, 陳映蓉. 從美國FDA對藥品不良事件主動監視系統談臺灣主動監視平台的可能性. 臺灣臨床藥學雜誌 2017年｜25卷1期: 275-281. dio: 10.6168/FJCP.2017.2504.01.

5. Chen CC, Hsiao FY, Shen LJ, Wu CC. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. Medicine (Baltimore). 2017; 96(34):e7883. doi: 10.1097/MD.0000000000007883.

6. Tsun-Jen Wen, Yu-Wen Wen, Chun-Ru Chien, Shao-Chin Chiang, William Wei-Yuan Hsu, Li-Jiuan Shen, Fei-Yuan Hsiao. Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis in chemotherapy-induced febrile neutropenia among breast cancer and Non-Hodgkin’s lymphoma patients under Taiwan’s national health insurance system. Journal of Evaluation in Clinical Practice 2017; 23(2): 288-293. doi: 10.1111/jep.12597. [Epub 2016 Aug 4]. (SCI)

7. Chen-Yu Wang, Zhen-Fang Lin, Chii-Ming Lee, Yi-Wen Tsai, Ting-Ying Huang, Li-Jiuan Shen, Fei-Yuan Hsiao. Concomitant Use of Calcium Channel Blockers with Dual Antiplatelet Therapy and Re-hospitalization for Acute Coronary Syndrome. Pharmacoepidemiology and Drug Safety 2017; 26(3): 229-238. doi: 10.1002/pds.4147. [Epub 2017 Jan 9]. (SCI)

8. Yao-Chun Wen, Fei-Yuan Hsiao, K. Arnold Chan, Zhen-Fang Lin, Li-Jiuan Shen*, Cheng-Chung Fang*. Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study. The Journal of Infectious Diseases 2017; 215(4): 503-509. doi: 10.1093/infdis/jiw603.

9. 王雪如, 楊秀琍, 林書巧, 林慧玲, 王春玉, 沈麗娟, 林秋杏. 臺灣醫院藥局調製藥品之初次調查及評估. 臺灣醫學 2017年｜20卷6期: 570-578. doi: 10.6320/FJM.2016.20(6).2

10. Yin Lo, Li-Jiuan Shen, Wen-Hwei Chen, Yaa-Hui Dong, Fe-Lin Lin Wu. Risk factors of ifosfamide-related encephalopathy in adult patients with cancer: a retrospective analysis. Journal of the Formosan Medical Association 2016; 115(9): 744-751. doi: 10.1016/j.jfma.2015.07.016. [Epub 2015 Aug 21]. (SCI)

11. Chien-Chih Wu, Li-Jiuan Shen, Li-Feng Hsu, Wen-Je Ko, Fe-Lin Lin Wu. Pharmacokinetics of Vancomycin in Adults Receiving Extracorporeal Membrane Oxygenation. Journal of the Formosan Medical Association 2016; 115(7): 560-570. doi: 10.1016/j.jfma.2015.05.017. [Epub 2015 Jun 27]. (SCI)

12. Zhen-Fang Lin, Chen-Yu Wang, Li-Jiuan Shen, Fei-Yuan Hsiao, Fe-Lin Lin Wu. Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan. Canadian Journal of Diabetes 2016; 40(3): 264-269. doi: 10.1016/j.jcjd.2015.12.006. [Epub 2016 Mar 15].

13. Wan-Tseng Hsu, Li-Jiuan Shen, Chii-Ming Lee. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. Journal of the Formosan Medical Association 2016; 115(5): 335-342. doi: 10.1016/j.jfma.2015.11.014. [Epub 2016 Jan 13]. (SCI)

14. Chia-Hui Lin, Fei-Yuan Hsiao, Yen-Bin Liu, Susan Shur-Fen Gau, Chi-Chuan Wang, Li-Jiuan Shen. Antidepressants and valvular heart disease: A nested case-control study in Taiwan. Medicine (Baltimore) 2016; 95(14): e3172. doi: 10.1097/MD.0000000000003172.

15. Tzyy-Harn Yeh, Yun-Ru Chen, Szu-Ying Chen, Wei-Chiang Shen, David Ann, Jennica Zaro, Li-Jiuan Shen. Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Molecular Pharmaceutics 2016; 13(1): 262-271. doi: 10.1021/acs.molpharmaceut.5b00706. [Epub 2015 Dec 17]. (SCI)

16. 林慧玲, 林淑文, 何藴芳, 沈麗娟. 六年制藥學系課程設計的理念與原則：以醫院藥學為例. 台灣醫學2016年｜20卷1期: 33-39. doi: 10.6320/FJM.2016.20(1).5

17. 顧記華, 沈麗娟, 陳基旺, 何藴芳, 林慧玲. 臺灣六年制藥學教育的創建. 台灣醫學2016年｜20卷1期: 27-32. doi: 10.6320/FJM.2016.20(1).4

18. Shu-Chiao Lin, Chih-Fen Huang, Li-Jiuan Shen, Hsueh-Ju Wang, Chia-Yu Lin, Fe-Lin Lin Wu. Formulation and Stability of an Extemporaneous 0.02% Chlorhexidine Digluconate Ophthalmic Solution. Journal of the Formosan Medical Association 2015, 114(12): 1162-1169. doi: http://dx.doi.org/10.1016/j.jfma.2014.08.003. [Epub 2014 Sep 24]. (SCI)

19. Shin-Yi Lin, Sung-Chun Tang, Li-Kai Tsai, Shin-Joe Yeh, Li-Jiuan Shen, Fe-Lin Lin Wu, Jiann-Shing Jeng. Incidence and risk factors for Acute Kidney Injury Following Mannitol Infusion in Patients with Acute Stroke: A Retrospective Cohort Study. Medicine (Baltimore) 2015; 94(47): e2032. doi: 10.1097/MD.0000000000002032. (SCI)

20. Fe-Lin Lin Wu, Sheau-Shan Liu, Ting-Ya Yang, Ming-Fang Wen, Shu-Wen Lin, Chih-Fen Huang, Kuo-Chuan Wang, Li-Jiuan Shen. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance. Therapeutic Drug Monitoring 2015; 37(5): 609-618. doi: 10.1097/FTD.0000000000000187. (SCI)

21. Hung-Lin Chen, Li-Jiuan Shen, Chih-Ping Wei, Hsin-Min Lu, and Fei-Yuan Hsiao. Decision to Adopt Medical Technology under the National Health Insurance System in Taiwan: Case Study of New Molecular Targeted Drugs among Non-Small Cell Lung Cancer Patients. Journal of Evaluation in Clinical Practice 2015; 21(5): 808-816. doi: 10.1111/jep.12382. [Epub 2015 Jun 11]. (SCI)

22. 林書巧、楊秀琍、吳以安、林慧玲、沈麗娟、王春玉、王雪如：美國醫院藥局調製相關規範. 臺灣臨床藥學雜誌2015年｜23卷3期: 181-187. doi： 10.6168/FJCP.2015.2303.03

23. 林欣儀, 陳以雯, 康皓程, 吳宜真, 朱蓁蓁, 林慧玲, 沈麗娟, 黃織芬. Warfarin在亞洲族群之治療目標準則. 臺灣臨床藥學雜誌2015年｜23卷3期: 189-202. doi: 10.6168/FJCP.2015.2303.04

24. Chin-I Hsu, Fei-Yuan Hsiao, Fe-Lin Lin Wu, Li-Jiuan Shen. Adherence and Medication Utilization Patterns of Fixed-dose and Free Combination of Angiotensin Receptor Blocker/Thiazide Diuretics among Newly Diagnosed Hypertensive Patients: a Population-based Cohort Study. International Journal of Clinical Practice 2015, 69(7): 729-737. doi: 10.1111/ijcp.12591. [Epub 2014 Nov 14]. (SCI)

25. 楊秀琍, 林書巧, 吳以安, 林慧玲, 沈麗娟, 王春玉, 王雪如. 簡介歐盟國家現今醫院藥局調製相關規範. 臺灣臨床藥學雜誌2015年｜23卷2期: 91-98. doi: 10.6168/FJCP.2015.2302.03

26. Chien-Chih Wu, Chih-Fen Huang, Li-Jiuan Shen, Fe-Lin Lin Wu. Successful Elimination of Methotrexate by Continuous Veno-venous Haemofiltration in a Psoriatic Patient with Methotrexate Intoxication. Acta Dermato-Venereologica 2015; 95(5): 626–627. doi: 10.2340/00015555-2041. [Epub ahead of print]. SHORT COMMUNICATION (SCI)

27. Tan-Wei Chew, Churn-Shiouh Gau, Yu-Wen Wen, Li-Jiuan Shen, C. Daniel Mullins and Fei-Yuan Hsiao. Epidemiology, Clinical Profile and Treatment Patterns of Venous Thromboembolism in Cancer Patients in Taiwan: A Population-based Study. BMC Cancer 2015; 15: 298. doi: 10.1186/s12885-015-1200-6. (SCI)

28. Ajit Dhananjay Jagtap, Pei-The Chang, Jia-Rong Liu, Hsio-Chun Wang, Nagendra B. Konderkar, Li-Jiuan Shen, Hsiang-Wen Tseng, Grace Shiahuy Chen, Ji-Wang Chern. Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia. European Journal of Medicine Chemistry 2014; 85: 268-288. doi: 10.1016/j.ejmech.2014.07.108. [Epub 2014 Jul 30].

29. Shin-Yi Lin, Sung-Chun Tang, Li-Kai Tsai, Shin-Joe Yeh, Yu-Jen Hsiao, Yu-Wei Chen, Kai-Hsiang Chen, Baksau Yip, Li-Jiuan Shen, Fe-Lin Lin Wu, Jiann-Shing Jeng. Orolingual Angioedema After Alteplase Therapy of Acute Ischaemic Stroke: Incidence and Risk of Prior Angiotensin-Converting Enzyme Inhibitors Use. European Journal of Neurology 2014; 21(10): 1285-1291. doi: 10.1111/ene.12472. [Epub 2014 Jun 9]. (SCI)

30. 黃筱芳、陳莉卿、徐珮容、黃嗣棻、林綺珊、康皓程、沈麗娟、洪冠予. 病人安全與品質提升：從管理架構到專案改善.台灣醫學2014年｜18卷5期: 558-565. doi： 10.6320/FJM.2014.18(5).09

31. Fe-Lin Lin Wu, Tzyy-Harn Yeh, Ying-Luen Chen, Yu-Chin Chiu, Ju-Chen Cheng, Ming-Feng Wei, Li-Jiuan Shen. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular Pharmaceutics 2014; 11(8): 2777-2786. doi: 10.1021/mp5001372. [Epub 2014 Jun 30]. (SCI)

32. Shan-Erh Lin, Fe-Lin Lin Wu, Ming-Feng Wei, Li-Jiuan Shen. Depletion of arginine by recombinant arginine deiminase (rADI) induces nNOS-activated neurotoxicity in neuroblastoma cells. BioMed Research International 2014; Article ID 589424, 8 pages. doi: 10.1155/2014/589424. Epub 2014 Jul 14. (SCI)

33. Tzyy-Harn Yeh, Fe-Lin Lin Wu, Li-Jiuan Shen. Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells. Journal of Drug Targeting 2014; 22(6): 528-535. doi: 10.3109/1061186X.2014.905947. [Epub 2014 Apr 14]. (SCI)

34. Yu-Ting Liao, Shu-Chen Kuo, Yi-Tzu Lee, Chien-Pei Chen, Shu-Wen Lin, Li-Jiuan Shen, Chang-Phone Fung, Wen-Long Cho, and Te-Li Chen. Sheltering effect and indirect pathogenesis of carbapenem resistant Acinetobacter baumannii in polymicrobial infection. Antimicrobial Agents and Chemotherapy 2014; 58(7): 3983-3990. doi: 10.1128/AAC.02636-13. (SCI)

35. Guan-Lin Chen, Fei-Yuan Hsiao, Yaa-Hui Dong, Li-Jiuan Shen, Fe-Lin Lin Wu. Statins and the Risk of Liver Injury: A Population-based Case-control Study. Pharmacoepidemiology and Drug Safety 2014; 23(7): 719-725. doi: 10.1002/pds.3646. [Epub 2014 May 14]. (SCI)

36. Yaa-Hui Dong, Chia-Hsuin Chang, Fe-Lin Lin Wu, Li-Jiuan Shen, Peter Calverley, Claes-Goran Löfdahl, Mei-Shu Lai, Donald Mahler. Use of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and the Risk of Tuberculosis and Influenza: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chest 2014; 145(6): 1286-1297. doi: 10.1378/chest.13-2137. (SCI)

37. Fuming Qiu, Yun-Ru Chen, Xiyong Liu, Cheng-Ying Chu, Li-Jiuan Shen, Jinghong Xu, Shikha Gaur, Henry Jay Forman, Hang Zhang, Shu Zheng, Yun Yen, Jian Huang, Hsing-Jien Kung, David K. Ann. Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells. Science Signaling 2014; 7(319), ra31. dio: 10.1126/scisignal.2004761. (SCI)

38. Chen-Fang Lin, Li-Jiuan Shen, Fei-Yuan Hsiao, Churn-Shiouh Gau, Fe-Lin Lin Wu. Sex Differences in the Treatment and Outcome of Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-based Study. Journal of Women’s Health 2014; 23(3): 238-245. doi: 10.1089/jwh.2013.4474.

39. Chia-Yu Lin, Li-Jiuan Shen, Chih-Fen Huang, Hsiu-Li Yang, Ying-Jung Chen, Fe-Lin Lin Wu. Beyond-Use Date of Extemporaneous Morphine Hydrochloride Oral Solution. Journal of Food and Drug Analysis 2013; 21(2): 142-146. (SCI)

40. Wen-Hwei Chen, Li-Jiuan Shen, Ru-Jiun Guan, Fe-Lin Lin Wu*. Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center. Journal of the Formosan Medical Association 2013; 112(4): 193-200. doi: 10.1016/j.jfma.2011.11.026. [Epub 2012 Apr 28]. (SCI)

41. 黃淑慧、林淑文、沈麗娟. 臺灣之畢業後藥學教育. 醫療品質雜誌2013年｜第7卷第2期: 19-22.

42. Hsin Hu, Fe-Lin Lin Wu, Fu-Chang Hu, Hui-Yuan Yang, Shu-Wen Lin, Li-Jiuan Shen. Effectiveness of education programs about oral antibiotic suspensions in pediatric outpatient services. Pediatrics and Neonatology 2013; 54(1): 34-42. doi: 10.1016/j.pedneo.2012.10.002. Epub 2012 Dec 8. (SCI)

43. Chen-Fang Lin, Li-Jiuan Shen, Fe-Lin Lin Wu, Chyi-Huey Bai, Churn-Shiouh Gau. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan. British Journal of Clinical Pharmacology 2012; 74 (5):824-834. doi: 10.1111/j.1365-2125.2012.04250.x. (SCI)

44. Chen-Fang Lin, Fe-Lin Lin Wu, Shu-Wen Lin, Chyi-Huey Bai, Ding-Cheng Chan, Churn-Shiouh Gau, Fei-Yuan Hsiao, Li-Jiuan Shen. Age, dementia and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the national health insurance coverage. Drugs & Aging 2012; 29(10): 819-828. doi: 10.1007/s40266-012-0011-6. (SCI)

45. Fe-Lin Lin Wu*, Yung-Ming Chen, Tai-Shuan Lai, Li-Jiuan Shen, Yunn-Fang Ho, Yi-Ting Lee, Ming-Show Wu, Shuei-Liong Lin, Kwan-Dun Wu. Does Chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan? Nephron Clinical Practice 2012 Oct; 120(4):c215-c222. doi: 10.1159/000341120.

46. 關如珺, 沈麗娟, 羅英, 陳文慧. Rituximab用於晚期濾泡性淋巴瘤的治療. 台灣醫學2012年｜第16卷4期: 416–424. doi： 10.6320/FJM.2012.16(4).12

47. Hsiu-Li Yang, Li-Jiuan Shen, Chih-Fen Huang, Chia-Yu Lin, Wen-Hwei Chen, Ya-Ting Hsieh, Fe-Lin Lin Wu. Are Brand-Name Drugs of Better Quality than Generics? Research at a Medical Center in Taiwan. Journal of Food and Drug Analysis 2012; 20(1): 6-11. (SCI)

48. I-Lin Tsai, Hsiang-Yin Liu, Ping-Hung Kuo, Jann-Yuan Wang, Li-Jiuan Shen, Ching-Hua Kuo. Quantitative determination of isoniazid in biological samples by cation-selective exhaustive injection-sweeping-micellar electrokinetic chromatography. Analytical and Bioanalytical Chemistry 2011; 401(7): 2205-2214. doi: 10.1007/s00216-011-5285-8. [Epub 2011 Aug 11]. (SCI)

49. Chen-Fang Lin, Churn-Shiouh Gau, Fe-Lin Lin Wu, Fei-Yuan Hsiao, Chyi-Huey Bai, Li-Jiuan Shen. Impact of ezetimibe co-administered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan. Clinical Therapeutics 2011; 33(9): 1120-1131. doi: 10.1016/j.clinthera.2011.08.002. [Epub 2011 Aug 27]. (SCI)

50. Shen LJ, Chou H, Huang CF, Chou GM, Chan WK, Wu FL. Economic benefits of sponsored clinical trials on pharmaceutical expenditures at a medical center in Taiwan. Contemporary Clinical Trials 2011; 32(4):485-491. doi: 10.1016/j.cct.2011.04.003. Epub 2011 Apr 17. (SCI)

51. Wu FL, Liang YF, Chang YC, Yo HH, Wei MF, Shen LJ*. RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells. Journal of Biomedical Science 2011; 18(1): 25. doi: 10.1186/1423-0127-18-25 (SCI)

52. 朱蓁蓁,沈麗娟,何藴芳,林慧玲. 用藥安全推動成果與展望. 醫療品質雜誌2009年｜第3卷第2期: 23-27.

53. 徐莞曾, 沈麗娟, 何藴芳, 黃肇明, 林慧玲. 臺灣與日本保險特約藥局藥事服務費支付現況及分析. 台灣臨床藥學雜誌2008年｜第16卷第3期: 33-50.

54. Hao-Hsin Yu, Fe-Lin Lin Wu, Shan-Erh Lin, Li-Jiuan Shen*. Recombinant arginine deiminase reduces inducible nitric oxide synthase (iNOS)-mediated neurotoxicity in a co-culture of neurons and microglia. Journal of Neuroscience Research 2008; 86(13): 2963-2972. doi: 10.1002/jnr.21740. (corresponding author) (SCI)

55. Fe-Lin Lin Wu, Yun-Ru Chen, Marie Lin, Herng-Der Chern, Li-Jiuan Shen*. Variability in the Frequency of Single Nucleotide Polymorphisms of N-acetyl Transferase 2 (NAT2) Gene among the Different Ethnic Groups in Taiwan. Journal of Food and Drug Analysis 2008; 16(5): 15-20. (corresponding author) (SCI)

56. Yi-Shiu Lin, Li-Jiuan Shen, Yuun-Fan Ho, Fe-Lin Lin Wu. The cost of adverse drug reaction: a case report of phenytoin hypersensitivity after re-exposure in a patient with sensitivity history. Formosan Journal of Medicine 2008, 12: 537-542.

57. 林慧玲, 郭錦樺, 陳宜君, 黃惠玟, 沈麗娟. 肺結核藥物治療成效與NAT2基因多型性於臺灣特定縣市族群之探究. 臺灣臨床藥學雜誌2008年｜第16卷第2期: 1-15.

58. Li-Jiuan Shen, Fe-Lin Lin Wu, Yunn-Fang Ho, Karin C.S., Chen Lin. Evolution of Pharmacy Education in Taiwan. Journal of the Korean Society of Pharmaceutical Regulatory Sciences 2008; 3(1, 2): 71-77.

59. Shen LJ, Wu Lin FL. Nanomedicines in renal transplant rejection – focus on Sirolimus. International Journal of Nanomedicine 2007, 2(1): 25-32. (SCI)

60. Shen LJ*, Shen WC. Drug Evaluation: ADI-PEG-20 --a pegylated arginine deiminase for arginine-auxotrophic cancers. Current Opinion in Molecular Therapeutics 2006, 8(3): 240-248. (corresponding author)

61. Shen LJ, Beloussow K, Shen WC. Modulation of arginine metabolic pathway as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Letters 2006, 231(1): 30-35. (SCI)

62. Shen LJ, Beloussow K, Shen WC. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochemical Pharmacology 2005, 69(1): 97-104. (SCI)

63. Kuo CL, Wang RB, Shen LJ, Lien LL, Lien EJ. G-protein coupled receptors: SAR analyses of neurotransmitters and antagonists. Journal of Clinical Pharmacy and Therapeutics 2004, 29(3): 279-298. (SCI)

64. Shen LJ, Lin WC, Beloussow K, Hosoya KI, Terasaki T, Ann DK, Shen WC. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochemical Pharmacology 2003, 66(10): 1945-1952. (SCI)

65. Shen LJ, Lin WC, Beloussow K, and Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Letters 2003; 191(2): 165-170. (SCI)

66. Wu Lin FL, Shen LJ, Yang Chun-Chi, Chen CH. Stability of Extemporaneous Suspensions of Co-trimazole. The Chinese Pharmaceutical Journal 1999; 519(1): 93-102. (SCI)

67. Wu Lin FL, Sheu CJ, Chen WH, Shen LJ, Chen CH. Practical Guide for the Administration of Antimicrobial Injections in a Teaching Hospital. Formosa Journal of Clinical Pharmacy 1997; 5: 163-177.

68. Shen LJ, Wu Lin FL. Adverse Drug Reaction: Thrombocytopenia. Continuing Medical Education 1996; 6(4): 354 -359.

69. Wu Lin FL, Yang CC, Shen LJ, Chen CY. Adverse Drug Reactions in a Medical Ward. Journal of the Formosan Medical Association 1996; 95(3): 241-246. (SCI)